Edition:
United Kingdom

Audentes Therapeutics Inc (BOLD.OQ)

BOLD.OQ on NASDAQ Stock Exchange Global Market

37.90USD
19 Jul 2019
Change (% chg)

$-0.18 (-0.47%)
Prev Close
$38.08
Open
$38.16
Day's High
$38.49
Day's Low
$37.52
Volume
110,051
Avg. Vol
154,740
52-wk High
$42.48
52-wk Low
$18.00

About

Audentes Therapeutics, Inc. is an early-stage biotechnology company. The Company is focused on developing and commercializing gene therapy products for patients suffering from serious, life-threatening rare diseases caused by single gene defects. The Company has a portfolio of product candidates, including AT132 for the... (more)

Overall

Beta: --
Market Cap(Mil.): $1,686.58
Shares Outstanding(Mil.): 44.29
Dividend: --
Yield (%): --

Financials

  BOLD.OQ Industry Sector
P/E (TTM): -- 95.83 34.03
EPS (TTM): -3.79 -- --
ROI: -38.84 7.72 12.70
ROE: -40.46 8.23 17.29

Earnings vs. Estimates